Cytokinetics, Incorporated
IT ˙ BIT ˙ US23282W6057
62,32 € 0,00 (0,00%)
2026-06-03
DEL PRIS
SecurityIT:1CYTK / Cytokinetics, Incorporated
InstitutionCreative Planning
Latest Disclosed Ownership107,760 shares
Latest Disclosed Value $ 7,102,472
Creative Planning reports 11.16% increase in ownership of 1CYTK / Cytokinetics, Incorporated

On May 12, 2026 - Creative Planning filed a 13F-HR form disclosing ownership of 107,760 shares of Cytokinetics, Incorporated (IT:1CYTK) valued at $5,819,040 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 96,939 shares of Cytokinetics, Incorporated. This represents a change in shares of 11.16% during the quarter. The current value of the position is $6,715,603 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F CYTOKINETICS COM NEW 23282W605 107,760 10,821 11.16 7,102 15.31 0.0048
2026-02-17 2025-12-31 13F CYTOKINETICS COM NEW 23282W605 96,939 9,629 11.03 6,159 28.37 0.0044
2025-11-14 2025-09-30 13F CYTOKINETICS COM NEW 23282W605 87,310 39,248 81.66 4,799 202.33 0.0037
2025-08-08 2025-06-30 13F CYTOKINETICS COM NEW 23282W605 48,062 14,485 43.14 1,588 17.64 0.0014
2025-05-15 2025-03-31 13F CYTOKINETICS COM NEW 23282W605 33,577 12,273 57.61 1,349 34.63 0.0013
2025-02-14 2024-12-31 13F CYTOKINETICS COM NEW 23282W605 21,304 -2,362 -9.98 1,002 -19.78 0.0010
2024-10-11 2024-09-30 13F CYTOKINETICS COM NEW 23282W605 23,666 7,939 50.48 1,250 46.60 0.0012
2024-08-15 2024-06-30 13F CYTOKINETICS COM NEW 23282W605 15,727 5,649 56.05 852 20.68 0.0009
2024-05-13 2024-03-31 13F CYTOKINETICS COM NEW 23282W605 10,078 3,607 55.74 707 30.74 0.0008
2024-02-14 2023-12-31 13F CYTOKINETICS COM NEW 23282W605 6,471 6,471 540 0.0010
2017-10-17 2017-09-30 13F CYTOKINETICS COM NEW 23282W605 0 -83 -100.00 0 -100.00
2017-07-12 2017-06-30 13F CYTOKINETICS COM NEW 23282W605 83 -42 -33.60 1 -50.00 0.0000
2017-04-07 2017-03-31 13F CYTOKINETICS COM NEW 23282W605 125 42 50.60 2 100.00 0.0000
2017-01-09 2016-12-31 13F CYTOKINETICS COM NEW 23282W605 83 0 0.00 1 0.00 0.0000
2016-10-12 2016-09-30 13F CYTOKINETICS COM NEW 23282W605 83 0 0.00 1 0.00 0.0000
2016-07-12 2016-06-30 13F CYTOKINETICS COM NEW 23282W605 83 0 0.00 1 0.00 0.0000
2016-04-08 2016-03-31 13F CYTOKINETICS COM NEW 23282W605 83 0 0.00 1 0.00 0.0000
2016-01-11 2015-12-31 13F CYTOKINETICS COM NEW 23282W605 83 0 0.00 1 0.00 0.0000
2015-10-09 2015-09-30 13F CYTOKINETICS COM NEW 23282W605 83 -93,026 -99.91 1 -99.84 0.0000
2015-07-09 2015-06-30 13F CYTOKINETICS COM NEW 23282W605 93,109 93,026 112,079.52 626 62,500.00 0.0057
2015-04-13 2015-03-31 13F CYTOKINETICS COM NEW 23282W605 83 83 0.00 1 0.0000
2015-01-29 2014-12-31 13F CYTOKINETICS COM NEW 23282W605 0 -83 -100.00 0
2014-10-10 2014-09-30 13F CYTOKINETICS COM NEW 23282W605 83 0 0.00 0 0.0000
2014-08-20 2014-06-30 13F CYTOKINETICS COM NEW 23282W605 83 0 0.00 0 -100.00
2014-04-11 2014-03-31 13F CYTOKINETICS COM NEW 23282W605 83 0 0.00 1 0.00 0.0000
2014-01-06 2013-12-31 13F CYTOKINETICS COM NEW 23282W605 83 0 0.00 1 0.00 0.0000
2013-10-10 2013-09-30 13F CYTOKINETICS COM NEW 23282W605 83 83 1 0.0000
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.